Naloxone and Clinical Outcomes in Suspected Opioid-Associated Out-of-Hospital Cardiac Arrests - Scorecard - MDSpire

Naloxone and Clinical Outcomes in Suspected Opioid-Associated Out-of-Hospital Cardiac Arrests

  • By

  • Ralph C. Wang

  • Jake Toy

  • Juan Carlos C. Montoy

  • Juliana Tolles

  • Paul F. Ehlers

  • J Joelle Donofrio-Odmann

  • James J. Menegazzi

  • Marianne Gausche-Hill

  • Robert M. Rodriguez

  • David G. Dillon

  • CAL-ROC Investigators

  • John M VanBuren

  • Nichole Bosson

  • Dustin W Ballard

  • Amelia M Breyre

  • Senai Kidane

  • Zita Konik

  • Mark Luoto

  • Kevin Mackey

  • John S Rose

  • Shira Schlesinger

  • Alexander Schmalz

  • Daniel Sheperd

  • Pranav Shetty

  • Reza Vaezazizi

  • Sachin Agarwal

  • Ann Johnson

  • Roger J Lewis

  • Jason McMullan

  • Stephen Sanko

  • Manish I Shah

  • Hernando Garzon

  • Daniel Nishijima

  • Debbie Y Madhok

  • Mary P Mercer

  • Christopher J Coyne

  • Christopher A Kahn

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Naloxone on Outcomes in Suspected Drug-Related Cardiac Arrests Outside of Hospital Settings

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdults (aged ≥18 years) with suspected opioid-associated OHCA
Care Setting

Key Highlights

  • Clarify source of statistics regarding increase in drug-related OHCAs.

Guideline-Based Recommendations

Diagnosis

  • Use of the Naloxone Cardiac Arrest Decision Instrument (NACARDI) for identifying OA-OHCA
  • Refer to specific American Heart Association guidelines.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Include specific outcomes related to naloxone administration.

        Clinical Best Practices

        • Add recommendation for ongoing training for EMS clinicians on naloxone use.

        Related Resources & Content

        Original Source(s)

        Related Content